Display options
Cite
Sambursky R, Shapiro N. Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection. Eur Clin Respir J. 2015;2:28245doi: 10.3402/ecrj.v2.28245.
Sambursky, R., & Shapiro, N. (2015). Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection. European clinical respiratory journal, 228245. https://doi.org/10.3402/ecrj.v2.28245
Sambursky, Robert, and Shapiro, Nathan. "Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection." European clinical respiratory journal vol. 2 (2015): 28245. doi: https://doi.org/10.3402/ecrj.v2.28245
Sambursky R, Shapiro N. Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection. Eur Clin Respir J. 2015 Dec 10;2:28245. doi: 10.3402/ecrj.v2.28245. eCollection 2015. PMID: 26672961; PMCID: PMC4676840.
Copy Download .nbib Format: NLM
Share it on

Eur Clin Respir J. 2015 Dec 10;2:28245. doi: 10.3402/ecrj.v2.28245. eCollection 2015.

Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.

European clinical respiratory journal

Robert Sambursky, Nathan Shapiro

Affiliations

  1. RPS Diagnostics, Sarasota, FL, USA; [email protected].
  2. Beth Israel Deaconess Medical Center, Boston, MA, USA.

PMID: 26672961 PMCID: PMC4676840 DOI: 10.3402/ecrj.v2.28245

Abstract

BACKGROUND: Challenges in the clinical differentiation of viral and/or bacterial respiratory infection lead to the misappropriation of antibiotics and increased healthcare costs. A tool to facilitate rapid and accurate point-of-care (POC) differentiation is needed.

METHODS AND FINDINGS: A prospective, single center, blinded, observational clinical trial was conducted at Beth Israel Deaconess Medical Center from December 2012 to August 2013 to determine the accuracy of a POC immunoassay to identify a clinically significant immune response to viral and/or bacterial infection. Sixty patients with acute febrile respiratory infection (19 pharyngitis and 41 lower respiratory tract infection [LRTI]) were enrolled. Participants provided fingerstick blood for immunoassay testing (myxovirus A [MxA] and c-reactive protein [CRP]) and four oropharyngeal samples for viral PCR and routine bacterial cell culture. A venous blood sample was collected. An ELISA was used to measure CRP and MxA. Paired serological testing was used to confirm atypical bacteria. A urine sample was provided for Streptococcus and Legionella antigen testing. Patients with suspected LRTI had sputum and blood cultures, chest X-ray, and WBC count measured. Viral infection was confirmed if oropharyngeal PCR was positive for viral pathogens. Bacterial infection was confirmed in positive throat or sputum cultures. Elevated immunoglobulin M antibodies or twofold increase in IgG antibodies between acute and convalescent phase indicated atypical bacteria. Positive Streptococcus or Legionella urine antigen assays also confirmed bacterial infection. The immunoassay correctly categorized subjects as 92% (22/24) negative, 80% (16/20) with bacterial infection, and 70% (7/10) with viral infection.

CONCLUSIONS: The interplay between an MxA value and a semi-quantitative CRP value can aid in the differentiation of infectious etiology. In isolation, neither MxA nor CRP alone is sensitive or specific. However, the pattern of results in a rapid immunoassay provides a sensitive and specific method to differentiate acute febrile respiratory infections. This diagnostic information may help reduce antibiotic misuse and resistance and lower healthcare costs.

Keywords: CRP; MxA; bacteria; immune response; immunoassay; point-of-care; respiratory infection; virus

References

  1. J Virol Methods. 1998 Feb;70(2):183-91 - PubMed
  2. J Med Virol. 1981;8(3):161-7 - PubMed
  3. Br J Gen Pract. 2003 May;53(490):358-64 - PubMed
  4. Pediatr Infect Dis J. 2010 Aug;29(8):731-5 - PubMed
  5. Fam Pract. 2009 Feb;26(1):10-21 - PubMed
  6. J Clin Lab Anal. 1990;4(3):231-5 - PubMed
  7. J Med Microbiol. 2014 Mar;63(Pt 3):441-52 - PubMed
  8. Ann N Y Acad Sci. 1982;389:406-18 - PubMed
  9. Pediatrics. 2005 Oct;116(4):826-32 - PubMed
  10. Clin Chem Lab Med. 2005;43(4):438-40 - PubMed
  11. Pediatr Res. 2006 Dec;60(6):770-4 - PubMed
  12. Clin Chem. 1997 Nov;43(11):2064-75 - PubMed
  13. Clin Infect Dis. 2005 Aug 1;41(3):345-51 - PubMed
  14. Scand J Prim Health Care. 2000 Mar;18(1):39-43 - PubMed
  15. J Med Virol. 1999 Dec;59(4):547-51 - PubMed
  16. Acta Radiol. 2002 Mar;43(2):159-63 - PubMed
  17. Pediatrics. 2007 Aug;120(2):e410-5 - PubMed
  18. Acta Paediatr. 1996 Feb;85(2):163-7 - PubMed
  19. J Virol. 1992 Aug;66(8):4705-9 - PubMed
  20. J Clin Microbiol. 1998 Feb;36(2):539-42 - PubMed
  21. Br J Gen Pract. 2013 Nov;63(616):e787-94 - PubMed
  22. Pediatrics. 2014 Mar;133(3):e538-45 - PubMed
  23. Allergy. 2001 Sep;56(9):895-8 - PubMed
  24. Chest. 1995 Nov;108(5):1288-91 - PubMed
  25. Paediatr Respir Rev. 2013 Mar;14(1):38-45 - PubMed
  26. BMC Infect Dis. 2012 Jun 12;12:134 - PubMed
  27. Eur Respir J. 1997 May;10(5):1125-9 - PubMed
  28. Eur J Clin Microbiol Infect Dis. 1999 Sep;18(9):665-8 - PubMed
  29. N Engl J Med. 1993 Nov 11;329(20):1437-41 - PubMed
  30. Clin Infect Dis. 2010 Jan 15;50(2):202-9 - PubMed
  31. J Microbiol Immunol Infect. 2010 Jun;43(3):222-7 - PubMed
  32. Scand J Prim Health Care. 1992 Sep;10 (3):226-33 - PubMed
  33. J Med Virol. 2002 Mar;66(3):417-20 - PubMed
  34. J Clin Microbiol. 2011 Jul;49(7):2631-6 - PubMed
  35. J Virol. 1991 Feb;65(2):968-71 - PubMed
  36. Eur Respir J. 2002 Nov;20(5):1254-62 - PubMed
  37. Pediatr Res. 1997 May;41(5):647-50 - PubMed
  38. BMJ. 2005 Jul 2;331(7507):26 - PubMed
  39. Ann Emerg Med. 2001 Jun;37(6):690-7 - PubMed
  40. J Clin Lab Anal. 2012 May;26(3):174-83 - PubMed
  41. JAMA. 2010 Feb 3;303(5):418; author reply 419-20 - PubMed
  42. J Infect. 2012 Dec;65(6):490-5 - PubMed
  43. Clin Infect Dis. 2004 Jul 15;39(2):206-17 - PubMed
  44. Arch Intern Med. 2008 Oct 13;168(18):2000-7; discussion 2007-8 - PubMed
  45. J Immunol. 1993 Mar 1;150(5):1715-26 - PubMed
  46. Clin Infect Dis. 2005 Aug 15;41(4):490-7 - PubMed
  47. Chest. 1995 Apr;107(4):1028-31 - PubMed
  48. Am J Med. 2008 Mar;121(3):219-25 - PubMed
  49. J Clin Microbiol. 1993 Jan;31(1):111-7 - PubMed
  50. Scand J Infect Dis. 2008;40(9):715-20 - PubMed
  51. N Engl J Med. 2003 Apr 17;348(16):1546-54 - PubMed
  52. Cytokine. 2009 Jul;47(1):65-8 - PubMed
  53. Br J Gen Pract. 2001 Dec;51(473):998-1000 - PubMed
  54. J Virol. 1989 Jun;63(6):2616-22 - PubMed
  55. Clin Chem. 1999 Apr;45(4):478-85 - PubMed
  56. J Clin Pathol. 1979 Dec;32(12):1253-6 - PubMed
  57. JAMA. 2009 Sep 9;302(10 ):1059-66 - PubMed
  58. Ann Intern Med. 2003 Jan 21;138(2):109-18 - PubMed
  59. J Pediatr. 2009 Mar;154(3):396-400, 400.e1 - PubMed
  60. J Infect Dis. 1990 May;161(5):982-7 - PubMed
  61. Pediatr Allergy Immunol. 2003 Oct;14(5):363-70 - PubMed
  62. Am J Respir Crit Care Med. 2008 Jan 15;177(2):208-18 - PubMed
  63. N Engl J Med. 1988 Aug 18;319(7):397-400 - PubMed
  64. Mayo Clin Proc. 1975 Jun;50(6):339-44 - PubMed
  65. Am J Med. 2004 Apr 15;116(8):529-35 - PubMed
  66. BMC Fam Pract. 2007 Mar 29;8:15 - PubMed
  67. BMJ. 2009 May 05;338:b1374 - PubMed
  68. Arch Dis Child. 1986 Jan;61(1):24-9 - PubMed
  69. Influenza Other Respir Viruses. 2013 Jul;7(4):567-73 - PubMed
  70. JAMA. 2010 May 26;303(20):2051-7 - PubMed
  71. J Pediatr. 1992 Jan;120(1):22-7 - PubMed
  72. Pediatr Int. 2006 Feb;48(1):54-7 - PubMed
  73. Pediatrics. 2015 Apr;135(4):e985-93 - PubMed

Publication Types